Flavobacterium species are nonfastidious, oxidase-positive, gram-negative rods that do not ferment glucose. These organisms are widely distributed in nature and in hospital environments [1] . Except for Flavobacterium meningosepticum, most species are rarely pathogenic in humans [1] [2] [3] . The isolation of Flavobacterium species CDC (Centers for Disease Control and Prevention) group lIb, which accounts for 2.5% of all nonfennentative gram-negative bacilli and includes the most common flavobacteria recovered from clinical specimens, frequently represents colonization in the absence of clinical disease [2, 3] . Nevertheless, these organisms have been linked to cases of pneumonia [4] , meningitis [5] , and bacteremia [3, 6] .
Flavobacterium indologenes, originally classified as a type strain of Flavobacterium species CDC group lIb, was validly designated by Yabuuchi et a1. in 1983 [7] . In 1984, Holmes et a1. [8] proposed another new species of Flavobacterium, F. gleum, which had also been previously labeled as a member of Flavobacterium species CDC group lIb. The phenotypic and genotypic characteristics of F. indologenes and F. gleum were clearly differentiated in 1990 [9] . We describe 12 patients with bacteremia caused by F. indologenes who were seen at our institution over a 3-year period. We highlight the pathogenic role of F. indologenes in bloodstream infection as well as its antimicrobial susceptibility pattern and cellular fatty acid profile.
Antimicrobialsusceptibility testing. MICs of 20 antimicrobial agents for the 12 blood isolates of F. indologenes were determined by use of the agar dilution method described by the National Committee for Clinical Laboratory Standards (NCCLS) [12] . The following antimicrobial agents were obtained as standard reference powders of known potency: cephalothin, clindamycin, erythromycin, gentamicin, netilmicin, amikacin, trimethoprim-sulfamethoxazole (TMP-SM2), and vancomycin (Sigma Chemical, St. Louis); piperacillin and minocycline (Lederle Laboratories, Pearl River, NY); cefotaxime (Hoechst AG, Frankfurt, Germany); ceftriaxone (Roche Laboratories, Nutley, NJ); ceftazidime (Glaxo Operations, Greenford, England); cefoperazone (Pfizer, New York, NY); moxalactam (Shionogi Phamaceutical, Osaka, Japan); aztreonam (Bristol-Myers Squibb Laboratories, New York); imipenem (Merck Sharp & Dome, West Point, PA); ofloxacin, (Daiichi Seiyaku, Tokyo); ciprofloxacin (Bayer AG, Leverkusen, Germany); and teicoplanin (Marion Merrill Dow, Kansas City, MO).
The drugs were incoporated into the agar in serial twofold concentrations that ranged from 0.03 p,g/mL to 128 p,g/mL. The MIC of each antibiotic was defined as the lowest concentration of the drug that inhibited visible growth of the organism. Staphylococcus aureus strain ATCC (American Type Culture Collection) 29213, Escherichia coli strain ATCC 25922, and Pseudomonas aeruginosa strain ATCC 27853 were used as controls in each set of tests.
Clinicalcharacteristics. The medical records of all patients whose blood cultures were positive for F. indologenes were studied retrospectively. Data on underlying diseases, other associated conditions (use of an indwelling catheter or ventilator and administration of chemotherapy), the clinical syndrome, day offirst in-hospital blood culture positive for F. indologenes, polymicrobial bacteremia, other site from which the organism was isolated, antibiotic regimens before and after blood culture results were available, complications (shock, acute renal failure, disseminated intravascular coagulation, or adult respiratory distress syndrome), and outcome were collected from clinical presentations.
Episodes of bacteremia that developed at least 72 hours after admission were regarded as nosocomial, while episodes of bacteremia identified by positive blood cultures earlier than 72 hours after admission were considered community acquired. Neutropenia was defined as a WBC count of <4 X 109/L. Antibiotic therapy was considered to be appropriate ifthe drugs chosen proved to be active against the isolate during susceptibility testing.
Results
Bacterial isolates. Twelve isolates of F. indologenes were identified, accounting for 0.26% of the total number of positive blood cultures over the 3-year period of this study. For all patients but one, at least two sets ofblood cultures were positive for F. indologenes. Subculture onto sheep blood agar within 24 hours of incubation revealed smooth, circular, yellow-pigmented colonies that were 1-2 mm in diameter. All isolates were oxidase-positive gram-negative rods that did not ferment glucose. On the basis of biochemical profiles produced by the API 20NE and Vitek GNI card, the probability that the organism was F. indologenes was determined to be >99%. All isolates failed to grow at 41°C, did not produce acid from xylose and L-arabinose, and were negative for esculin hydrolysis within 4 hours of incubation but positive after 24 hours of incubation. These results corresponded with the identification of the organism as F. indologenes.
F. indologenes was also isolated simultaneously from other sites in nine patients (75%) (table 1). Eight patients (67%) had polymicrobial bacteremia, and seven of these bacteremic episodes were nosocomial. The organisms most frequently cultured simultaneously with F. indologenes were nonfermentative gram-negative bacilli (six patients) and gram-positive cocci (three patients).
Antimicrobial susceptibility. The results of susceptibility tests with 20 antimicrobial agents are shown in table 2. All isolates were uniformly susceptible to piperacillin (MIC 9o , 4 p,gl mL), and 11 of the isolates (92%) were susceptible to cefoperazone (MIC 9 (), 16 p,g/mL), ceftazidime (MIC 9o , 8 p,g/mL), and minocycline (MIC 9o , 4 p,g/mL). Susceptibility to TMP-5M2, ofloxacin, and ciprofloxacin was variable. All but one of the isolates were resistant to vancomycin (MIC 9o , 16 p,g/mL). The isolates were consistently resistant to other ,8-1actam antibiotics including aztreonam and imipenem; to aminoglycosides; and to erythromycin, clindamycin, and teicoplanin.
Analysis of cellular fatty acids. The chromatogram of cellular fatty acids for one of the F. indologenes isolates (figure 1) was characterized by the presence of four major peaks and two minor peaks. All of the isolates had identical cellular fatty acid profiles.
Clinicalcharacteristicsofthepatients. The clinical characteristics of the 12 patients with F. indologenes bacteremia are summarized in table 1. Male patients predominated (67%), and the mean age was 47 years (range, 1--80 years); six patients (50%) were >60 years old. Underlying diseases were present in 10 patients: five had malignancies, three had multiple bums, and two were neutropenic (chemotherapy induced) when F. indologenes was isolated. F. indologenes bacteremia was nosocomial in nine patients (75%) and developed in all of these patients after the first week of hospitalization.
The underlying clinical syndromes included pneumonia (six patients), primary bacteremia (two patients), and pyonephrosis, peritonitis, biliary tract infection, and surgical wound infection (one patient each). All six cases of pneumonia were ventilator associated, and each patient had received ventilatory support for at least 1 week before developing bacteremia. Of these six patients, five had polymicrobial bacteremia, and four had cultures of tracheal aspirates that were positive for F. indologenes as well as other nonfermentative gram-negative bacilli. NOTE. Amp/Sulb = ampicillin/sulbactam; ARDS = adult respiratory distress syndrome; ARF = acute renal failure; COPD = chronic obstructive pulmonary disease; DIC = disseminated intravascular coagulation; PCND = percutaneous nephrotomy drainage; PTCD = percutaneous transhepatic cholangiography drainage; TBSA = total body surface area.
Before F. indologenes was isolated, all but three (patients 7, 11, and 12; table 1) of the 12 patients were treated with different combinations of two or more antibiotics that later proved inactive in vitro against the isolates. One patient (patient 10) had an aortic mycotic aneurysm due to Salmonella choleraesuis, which was complicated by duodenal perforation. This patient underwent graft interposition and duodenostomy with insertion of an indwelling drainage catheter. F. indologenes was isolated concurrently from multiple samples of the drained fluid and blood on the 14th hospital day, at which time the patient had clinical evidence of sepsis.
After blood cultures were found to be positive for F. indologenes, all but three (patients 3, 8, and 9) of the 12 patients were treated with appropriate antibiotics. The conditions of 10 patients improved clinically within 5 days of the initiation of treatment. Two (17%) of the patients, both of whom had pneumonia and presented with refractory shock, developed adult respiratory distress syndrome and/or acute renal failure; they died on the fifth and sixth day, respectively, after the bacteremic episodes.
Discussion
Flavobacterium species CDC group lIb as well as F. meningosepticum, which belong to the first natural group of flavobacteria designated by Holmes et al. [8] , are saccharolytic and indole positive [1] . Flavobacterium species CDC group IIb shares a number of phenotypic characteristics with strains of F. meningosepticum; however, unlike F. meningosepticum, this group is characterized by the production of a distinct orangeyellow pigment within 24 hours of culture on a blood agar plate, hydrolysis of starch, and lack of acidification of n-arabinose and galactose [1, 10] . The name F. indologenes was formerly proposed for all of the heterogeneous strains of Flavobacterium species CDC group lIb, and the name F. gleum was proposed for a genetically homogenous group within it [I, 7, 8] . Until 1990, Flavobacterium species CDC group lIb was divided into two species, F. indologenes and F. gleum, on the basis of biochemical reactions and DNA homology studies [9, 13] . To date, however, these two species are poorly characterized in most microbiological laboratories, partly because of the general lack of commercial identification systems available for full differentiation. In this study, all the isolates were identified as F. indologenes by means of conventional tests as well as by two commercial identification systems. Identification of these isolates was further confirmed with use of the biochemical tests described by Yabuuchi et al. [9] . The fact that these isolates had identical cellular fatty acid profiles indicates that they were identical at the species level [14] .
Flavobacteria are ubiquitous in nature and are found in soil, plants, foodstuffs, and water sources despite adequate chlorination [1, 3] . In the hospital, indwelling vascular catheters, vials, sink traps, feeding tubes, other fluid-associated equipment, and even disinfectants may become reservoirs for flavobacteria [1] [2] [3] 5] . Strains of Flavobacterium species CDC group lIb are found more commonly in clinical specimens than are all other flavobacteria combined, but most of the isolates are recovered with other bacteria and have been judged to be of questionable pathogenicity [1] [2] [3] [4] [5] [6] . Few cases of definite human infections due to Flavobacterium species CDC group lIb have been reported in the English-language literature since the mid-1970s [3] [4] [5] [6] . F. indologenes has been isolated from a patient with ventilatorassociated pneumonia only once before; in that case, the organism was recovered only from a tracheal aspirate [4] .
Bacteremia caused by Flavobacterium species CDC group Ilb is rare; to our knowledge, only 15 cases have been previously described, 14 of which were associated with a nosocomial outbreak [6] and one of which was associated with bilateral breast cancer [3] . Contaminated vascular catheters were thought to be the portals of entry for the organisms in these patients.
In the present study, patients who had severely debilitating diseases, malignancy, or neutropenia and had undergone various invasive procedures or had previously received broad-spectrum antibiotics during a long period of hospitalization were at high risk for bloodstream infections caused by F. indologenes. Tracheobronchial colonization with gram-positive cocci and gram-negative rods, particularly nonfermentative gramnegative bacilli that originated from a hospital environment, is common in mechanically ventilated patients [4, 15, 16] . The incidence of nosocomial pneumonia is high, especially during the first 8-10 days, among patients who receive prolonged respiratory assistance [17] . Our findings were consistent with those of other investigators. Furthermore, we emphasize that F. indologenes should be included in the list of pathogens that cause ventilator-associated pneumonia. Although flavobacteria are not considered part of the normal bacterial flora in humans, these organisms can indeed be recovered from various anatomical sites in healthy persons [I, 3] . For three of our patients (patients 7, 8, and 9), the infections were unrelated to any invasive procedure, and the patients had had no exposure to a hospital environment in the preceding 3 months. Because of the diverse conditions associated with the community-acquired and nosocomial infections and because of the different antibiotic resistance profiles of the isolates, the epidemiological association among these patients is not evident.
The pathogenic role of F. indologenes in patients with polymicrobial bacteremia is difficult to determine. Two of our patients (patients 1 and 4) with polymicrobial bacteremia died despite the fact that they received antibiotics with in vitro activity against F. indologenes, which suggests that the deaths might be not fully attributable to flavobacterial bacteremia. On the contrary, two other patients (patients 3 and 8) who had polymicrobial bacteremia recovered despite the administration of anitiobiotics without in vitro activity against F. indologenes.
However, the fact that three-fourths of the patients had F. indologenes recovered simultaneously from various sites in addition to blood indicates the invasive nature of this organism.
The susceptibility patterns of the isolates is partly consistent with those of Flavobacterium species CDC group lIb strains described by other authors [18] [19] [20] [21] . These organisms have been reported to be uniformly resistant to extended-spectrum penicillins, first-and second-generation cephalosporins, and aztreonam. Susceptibilities to clindamycin, erythromycin, tetracycline, aminoglycosides, third-generation cephalosporins, imipenem, and quinolones have varied. In the present study, piperacillin, cefoperazone, ceftazidime, and minocycline were the agents most active against the isolates, while ciprofloxacin was active to a lesser extent. The activities of other antibiotics were disappointing. The wide range of antibiotic resistance exhibited by these isolates, particularly those recovered from hospitalized patients exposed to prolonged antibiotic therapy (and thus selection pressure), causes a significant therapeutic dilemma in clinical settings.
It is difficult to determine optimal therapeutic regimens for treating severe infections due to F. indologenesbecause of the small number of patients in this series as well as the presence of polymicrobial bacteremia. Vancomycin had previously been recommended as the drug of choice for treatment of meningitis caused by F. meningosepticum in infants [22] . However, the high MICs of vancomycin for the F. indologenesisolates determined in the present study, as well as those for isolates of F. meningosepticum and other flavobacterial species described in earlier studies [18, 23] , indicate that this drug is not appropriate for treating flavobacterial infections.
Administration of the quinolones, especially ciprofloxacin, has resulted in clinical cures in patients with flavobacterial infections [21, 24] . One patient (patient 1) with F. indologenes and S. aureus bacteremia who was treated with intravenous ciprofloxacin (which had in vitro activity against the two isolates) died. However, another patient (patient 2), who was treated with oral ofloxacin for bacteremia due to the susceptible isolate, recovered. Clinical treatment of flavobacterial sepsis with a quinolone as the sole agent needs further evaluation. On the basis of the antimicrobial susceptibility patterns ofthese F. indologenes isolates and the limited clinical experience, we have concluded that piperacillin, cefoperazone, and ceftazidime may be included as part of the regimen for treating F. indologenes infections.
In summary, the findings ofthis study indicate that F. indologenes should be considered a potential pathogen in bloodstream infections in humans, especially in the setting of malignancy and with use of invasive procedures. The resistance of this organism to multiple antibiotics, including the newer ,B-Iactam agents and the high incidence of polymicrobial bacteremia make it difficult to determine optimal therapeutic options. The relatively low mortality among patients with F. indologenes bacteremia is not fully understood; further cases should be evaluated, and a study on the pathogenicity of this organism in humans should be conducted to elucidate this phenomenon.
